Dabur India Limited has submitted its investor presentation for the quarter ended September 30, 2026. The document details the company’s quarterly snapshot, performance highlights across consolidated and standalone segments, industry outlook, business segment performance including domestic and international operations, and brand communication strategies. It also covers healthcare, food and beverage segments, and ESG impact achieved.
Dabur India Investor Presentation Released
Dabur India Limited has officially released its investor presentation for the quarter ended September 30, 2026. This comprehensive document provides stakeholders with key insights into the company’s performance and strategic direction.
Quarterly Snapshot and Performance
The presentation includes a detailed Quarterly Snapshot, offering a brief overview of the period’s performance. Performance Highlights are elaborated upon, covering both Consolidated and Standalone financial results. For the consolidated figures, revenue stood at INR 3,563 Cr with an 11.6% growth, while operating profit was INR 633 Cr (7.5% growth). Standalone revenue reached INR 2,433 Cr with an 8.9% growth, and operating profit was INR 459 Cr (8.2% growth).
Segmental Performance
The company’s performance is further broken down by business segments. The Domestic Business accounts for 70%, with Home & Personal Care leading at 55% (10.9% growth), followed by Healthcare at 28% (6.9% growth), and Food & Beverages at 17% (17.4% growth). The International Business contributes 30%, with a significant 20.0% growth and revenue of INR 1,091 Cr.
Industry Outlook and Brand Communication
An Industry Outlook section addresses key factors such as Elevated Inflation, Geopolitical Tensions, and Stable Demand. The document also outlines Brand Communication strategies, showcasing impactful brand campaigns and influencer initiatives across various product categories including Oral Care, Hair Care, Home Care, Skin Care, Beverages, and Foods.
Healthcare and ESG Focus
The Healthcare segment, covering Health Supplements, Digestives, and OTC & Ethicals, is detailed. Notably, Dabur Chyawanprash saw low single-digit growth, while Honey declined mid-single digit. Digestives reported strong double-digit growth. The presentation concludes with an overview of ESG Impact Achieved, detailing progress in Environment, Social, and Governance aspects, alongside ESG Ranking Updates from DJSI, NSE, and Crisil.
Source: BSE
